Digital karyotyping identified amplification of an approximately 100-kb region on chromosome 18p11.32 that contains the coding of TYMS in metastatic CRC patients subjected to prior treatment with 5-FU-based therapy33. The gene discussed is TYMS; the disease is colorectal carcinoma.